Loading...
Intravitreal bevacizumab (Avastin) associated with secondary hyphaema in a case of proliferative sickle cell retinopathy
Intravitreal bevacizumab (Avastin) has been used off label for various conditions, including proliferative sickle cell retinopathy (PSR). Some authors have reported a more rapid resolution of the vitreous haemorrhage in Goldberg stage 4 PSR. Following injection of 1.25 mg of bevacizumab in each eye...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Publishing Group
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3029455/ https://ncbi.nlm.nih.gov/pubmed/22461855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.11.2009.2441 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|